Table 3 Detailed clinical characteristics of patients with CMV viremia who were subsequently diagnosed with PJP
Time from transplant to PJP diagnosis (years) | Time from CMV viremia to PJP diagnosis (months) | Peak CMV viral load in the year prior to PJP diagnosis (IU/mL) | Viremia present at time of PJP diagnosis | Valganciclovir therapy at time of PJP diagnosis | Ganciclovir-resistant CMV | |
|---|---|---|---|---|---|---|
Patients with PJP who had CMV viremia in the year preceding diagnosis of PJP | ||||||
1 | 11.9 | 0.9 | 826 | No | Yes | No |
2 | 7.3 | 3.0 | 6105 | Yes | Yes | No |
3 | 7.5 | 1.7 | 1264 | No | Yes | No |
4 | 1.1 | 0.9 | 1150 | Yes | Yes | Yes |
5 | 1.3 | 11.8 | 93,300 | Yes | Yes | No |
6 | 1.4 | 11.5 | 387 | Yes | No | No |
7 | 11.9 | 5.6 | 184,559 | No | Yes | No |
8 | 1.9 | 11.8 | 139,535 | No | No | No |
9 | 0.8 | 3.4 | 1034 | Yes | Yes | No |
Patients with PJP who had history of CMV viremia more than one year prior to diagnosis of PJP | ||||||
1 | 16.8 | 92.1 | NA | NA | NA | No |